Activation of MAPKs in the anti- β2GPI/β2GPI-induced tissue factor expression through TLR4/IRAKs pathway in THP-1 cells

Thrombosis Research

Volumn 130, Issue 4, 2012, Pages

  Zhou, Hong ^a,b   Chen, Dongdong ^b   Xie, Hongxiang ^b   Xia, Longfei ^b   Wang, Ting ^b   Yuan, Wei ^a   Yan, Jinchuan ^a  

^a AFFILIATED HOSPITAL OF JIANGSU UNIVERSITY   (China)

^b JIANGSU UNIVERSITY   (China)

Author keywords

2 glycoprotein I; Anti 2 glycoprotein I antibodies; MAPKs; Tissue factor; TLR4

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; BETA2 GLYCOPROTEIN 1 ANTIBODY; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE; JANUS KINASE 1; JANUS KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN SERINE THREONINE KINASE INHIBITOR; RESATORVID; SC 204013; SYNAPTOPHYSIN; THROMBOPLASTIN; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ACUTE MONOCYTIC LEUKEMIA; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; INHIBITION KINETICS; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANTIGEN-ANTIBODY COMPLEX; ANTIPHOSPHOLIPID SYNDROME; BETA 2-GLYCOPROTEIN I; CELL LINE, TUMOR; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; LEUKEMIA, MONOCYTIC, ACUTE; MAP KINASE SIGNALING SYSTEM; SULFONAMIDES; THROMBOPLASTIN; TOLL-LIKE RECEPTOR 4;

EID: 84866239340     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2012.08.303     Document Type: Article

References (42)

1. S. Miyakis, M.D. Lockshin, T. Atsumi, D.W. Branch, R.L. Brey, and R. Cervera International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) J Thromb Haemost 4 2006 295 306
2. A.A. Mehdi, I. Uthman, and M. Khamashta Antiphospholipid syndrome: pathogenesis and a window of treatment opportunities in the future J Eur J Clin Invest 40 2010 451 464
3. O. Amengual, T. Atsumi, M.A. Khamashta, and G.R. Hughes The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome J Thromb Haemost 79 1998 276 281
4. A. Lambrianides, C.J. Carroll, S.S. Pierangeli, C. Pericleous, W. Branch, and J. Rice Effects of polyclonal IgG derived from patients with different clinical types of the antiphospholipid syndrome on monocyte signaling pathways J Immunol 184 2010 6622 6628
5. J.H. Morrissey Tissue factor: an enzyme cofactor and a true receptor Thromb Haemost 86 2001 66 74
6. A.P. Owens, and N. Mackman Tissue factor and thrombosis: The clot starts here Thromb Haemost 104 2010 432 439
7. H. Bas de Laat, R.H. Derksen, and P.G. de Groot beta2-glycoprotein I, the playmaker of the antiphospholipid syndrome Clin Immunol 112 2004 161 168
8. B. Giannakopoulos, F. Passam, Y. Ioannou, and S.A. Krilis How we diagnose the antiphospholipid syndrome Blood 113 2009 985 994
9. H. Zhou, A.S. Wolberg, and R.A. Roubey Characterization of monocyte tissue factor activity induced by IgG antiphospholipid antibodies and inhibition by dilazep Blood 104 2004 2353 2358
10. K. Ma, R. Simantov, J.C. Zhang, R. Silverstein, K.A. Hajjar, and K.R. McCrae High affinity binding of beta 2-glycoprotein I to human endothelial cells is mediated by annexin II J Biol Chem 275 2000 15541 15548
11. M. Sorice, A. Longo, A. Capozzi, T. Garofalo, R. Misasi, and C. Alessandri Anti-beta2-glycoprotein I antibodies induce monocyte release of tumor necrosis factor alpha and tissue factor by signal transduction pathways involving lipid rafts Arthritis Rheum 56 2007 2687 2697
12. E. Raschi, M.O. Borghi, C. Grossi, V. Broggini, S. Pierangeli, and P.L. Meroni Toll-like receptors: another player in the pathogenesis of the anti-phospholipid syndrome Lupus 17 2008 937 942
13. J.E. Alard, F. Gaillard, C. Daridon, Y. Shoenfeld, C. Jamin, and P. Youinou TLR2 is one of the endothelial receptors for beta 2-glycoprotein I J Immunol 185 2010 1550 1557
14. K. Kobayashi, E. Matsuura, Q. Liu, J. Furukawa, K. Kaihara, and J. Inagaki A specific ligand for beta(2)-glycoprotein I mediates autoantibody-dependent uptake of oxidized low density lipoprotein by macrophages J Lipid Res 42 2001 697 709
15. B.C. Lutters, R.H. Derksen, W.L. Tekelenburg, P.J. Lenting, J. Arnout, and P.G. de Groot Dimers of beta 2-glycoprotein I increase platelet deposition to collagen via interaction with phospholipids and the apolipoprotein E receptor 2' J Biol Chem 278 2003 3383 3388
16. M.P. Sikara, J.G. Routsias, M. Samiotaki, G. Panayotou, H.M. Moutsopoulos, and P.G. Vlachoyiannopoulos {beta}2 Glycoprotein I ({beta}2GPI) binds platelet factor 4 (PF4): implications for the pathogenesis of antiphospholipid syndrome Blood 115 2010 713 723
17. H. Zhou, H. Wang, N. Li, Y. Yu, H. Huang, and Y. Yan Annexin A2 mediates anti-beta 2 GPI/beta 2 GPI-induced tissue factor expression on monocytes Int J Mol Med 24 2009 557 562
18. H. Zhou, Y. Yan, G. Xu, B. Zhou, H. Wen, and D. Guo Toll-like receptor (TLR)-4 mediates anti-β(2) GPI/β(2) GPI-induced tissue factor expression in THP-1 cells Clin Exp Immunol 163 2011 189 198
19. Y.C. Lu, W.C. Yeh, and P.S. Ohashi LPS/TLR4 signal transduction pathway Cytokine 42 2008 145 151
20. M. Kobayashi, S. Saitoh, N. Tanimura, K. Takahashi, K. Kawasaki, and M. Nishijima Regulatory roles for MD-2 and TLR4 in ligand-induced receptor clustering J Immunol 176 2006 6211 6218
21. N. Resman, J. Vasl, A. Oblak, P. Pristovsek, T.L. Gioannini, and J.P. Weiss Essential roles of hydrophobic residues in both MD-2 and toll-like receptor 4 in activation by endotoxin J Biol Chem 284 2009 15052 15060
22. Y. Gao, X. Fang, Y. Tong, Y. Liu, and B. Zhang TLR4-mediated MyD88-dependent signaling pathway is activated by cerebral ischemia-reperfusion in cortex in mice Biomed Pharmacother 63 2009 442 450
23. J. Brown, H. Wang, G.N. Hajishengallis, and M. Martin TLR-signaling networks: an integration of adaptor molecules, kinases, and cross-talk J Dent Res 90 2011 417 427
24. M.C. Lawrence, A. Jivan, C. Shao, L. Duan, D. Goad, and E. Zaganjor The roles of MAPKs in disease Cell Res 18 2008 436 442
25. R. Treisman Regulation of transcription by MAP kinase cascades Curr Opin Cell Biol 8 1996 205 215
26. M. Vega-Ostertag, K. Casper, R. Swerlick, D. Ferrara, E.N. Harris, and S.S. Pierangeli Involvement of p38 MAPK in the up-regulation of tissue factor on endothelial cells by antiphospholipid antibodies Arthritis Rheum 52 2005 1545 1554
27. C. López-Pedrera, P. Buendía, M.J. Cuadrado, E. Siendones, M.A. Aguirre, and N. Barbarroja Antiphospholipid antibodies from patients with the antiphospholipid syndrome induce monocyte tissue factor expression through the simultaneous activation of NF-κB/Rel proteins via the p38 mitogen-activated protein kinase pathway, and of the MEK-1/ERK pathway Arthritis Rheum 54 2006 301 311
28. 2GPI-induced Tissue Factor Expression in THP-1 Cells Thromb Haemost 106 2011 1158 1169
29. R. Willis, E.N. Harris, and S.S. Pierangeli Pathogenesis of the antiphospholipid syndrome Semin Thromb Hemost 2012 10.1055/s-0032-1311827
30. J. Boles, and N. Mackman Role of tissue factor in thrombosis in antiphospholipid antibody syndrome Lupus 19 2010 370 378
31. P. Redecha, R. Tilley, M. Tencati, J.E. Salmon, D. Kirchhofer, and N. Mackman Tissue factor: a link between C5a and neutrophil activation in antiphospholipid antibody-induced fetal injury Blood 110 2007 2423 2431
32. J. Zhang, and K.R. McCrae Annexin A2 mediates endothelial cell activation by antiphospholipid/anti-beta2 glycoprotein I antibodies Blood 105 2005 1964 1969
33. Z. Romay-Penabad, M.G. Montiel-Manzano, T. Shilagard, E. Papalardo, G. Vargas, and A.B. Deora Annexin A2 is involved in antiphospholipid antibody -mediated pathogenic effects in vitro and in vivo Blood 114 2009 3074 3083
34. R. Seger, and E.G. Krebs The MAPK signaling cascade FASEB J 9 1995 726 735
35. E.N. Glaros, W.S. Kim, and B. Gamer Myriocin-mediated up-regulation of hepatocyte apoA-I synthesis is associated with ERK inhibition Clin Sci (Lond) 118 2010 727 736
36. M.A. Khamashta, M.J. Cuadrado, F. Mujic, N.A. Taub, B.J. Hunt, and G.R. Hughes The management of thrombosis in the antiphospholipid antibody syndrome N Engl J Med 332 1995 993 997
37. S. Krnic-Barrie, C.R. O'Connor, S.W. Looney, S.S. Pierangeli, and E.N. Harris A retrospective review of 61 patients with antiphospholipid syndrome Arch Intern Med 157 1997 2101 2108
38. M.A. Crowther, J.S. Ginsberg, J. Julian, J. Denburg, J. Hirsh, and J. Douketis A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome N Engl J Med 349 2003 1133 1138
39. M. Vega-Ostertag, E.N. Harris, and S.S. Pierangeli Intracellular events in platelet activation induced by antiphospholipid antibodies in the presence of low doses of thrombin Arthritis Rheum 50 2004 2911 2919
40. J.A. McCubrey, L.S. Steelman, W.H. Chappell, S.L. Abrams, E.W. Wong, and F. Chang Roles of the Raf/MEK/ERK pathway in cell growth, malignant, transformation and drug resistance Biochim Biophys Acta 1773 2007 1263 1284
41. T. Kawamoto, M. Ii, T. Kitazaki, Y. Iizawa, and H. Kimura TAK-242 selectively suppresses Toll-like receptor 4-signaling mediated by the intracellular domain Eur J Pharmacol 584 2008 40 48
42. J.P. Luyendyk, J.D. Piper, M. Tencati, K.V. Reddy, T. Holscher, and R. Zhang A novel class of antioxidants inhibit LPS induction of tissue factor by selective inhibition of the activation of ASK1 and MAP kinases Arterioscler Thromb Vasc Biol 27 2007 1857 1863